APA (7th ed.) Citation

TB, T., DKH, T., N, B., BA, V., BWQ, T., Y, S., . . . ALA, W. (2024). Evaluation of ex vivo drug combination optimization platform in recurrent high grade astrocytic glioma: An interventional, non-randomized, open-label trial protocol. PloS one, 19(7), e0307818. https://doi.org/10.1371/journal.pone.0307818

Chicago Style (17th ed.) Citation

TB, Toh, et al. "Evaluation of Ex Vivo Drug Combination Optimization Platform in Recurrent High Grade Astrocytic Glioma: An Interventional, Non-randomized, Open-label Trial Protocol." PloS One 19, no. 7 (2024): e0307818. https://doi.org/10.1371/journal.pone.0307818.

MLA (9th ed.) Citation

TB, Toh, et al. "Evaluation of Ex Vivo Drug Combination Optimization Platform in Recurrent High Grade Astrocytic Glioma: An Interventional, Non-randomized, Open-label Trial Protocol." PloS One, vol. 19, no. 7, 2024, p. e0307818, https://doi.org/10.1371/journal.pone.0307818.